BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12940454)

  • 1. Bone mineral density in adult patients with Turner's syndrome: analyses of the effectiveness of GH and ovarian steroid hormone replacement therapies.
    Suganuma N; Furuhashi M; Hirooka T; Moriwaki T; Hasegawa Y; Mori O; Ogawa M
    Endocr J; 2003 Jun; 50(3):263-9. PubMed ID: 12940454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volumetric bone mineral density in young women with Turner's syndrome treated with estrogens or estrogens plus growth hormone.
    Bertelloni S; Cinquanta L; Baroncelli GI; Simi P; Rossi S; Saggese G
    Horm Res; 2000; 53(2):72-6. PubMed ID: 10971092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longitudinal study on bone mineral density until adulthood in girls with Turner's syndrome participating in a growth hormone injection frequency-response trial.
    Sass TC; De Muinck Keizer-Schrama SM; Stijnen T; Asarfi A; Van Leeuwen WJ; Van Teunenbroek A; Van Rijn RR; Drop SL
    Clin Endocrinol (Oxf); 2000 May; 52(5):531-6. PubMed ID: 10792330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial.
    Aycan Z; Cetinkaya E; Darendeliler F; Vidinlisan S; Bas F; Bideci A; Demirel F; Darcan S; Buyukgebiz A; Yildiz M; Berberoglu M; Bundak R
    Clin Endocrinol (Oxf); 2008 May; 68(5):769-72. PubMed ID: 17980015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study.
    Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; van Teunenbroek A; van Leeuwen WJ; Asarfi A; van Rijn RR; Drop SL;
    Pediatr Res; 2001 Sep; 50(3):417-22. PubMed ID: 11518831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of primary lack of estrogens and the influence of the age at the beginning of estrogen therapy on bone mineral density in patients with Turner's syndrome].
    Sowińska-Przepiera E; Andrysiak-Mamos E; Friebe Z; Kapczuk K; Pilarska K
    Endokrynol Pol; 2005; 56(2):145-53. PubMed ID: 16335682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral density in Turner's syndrome--a longitudinal study.
    Shaw NJ; Rehan VK; Husain S; Marshall T; Smith CS
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):367-70. PubMed ID: 9373461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of growth hormone treatment on bone mineral density and body composition in girls with turner syndrome.
    Ari M; Bakalov VK; Hill S; Bondy CA
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4302-5. PubMed ID: 16940444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hormone replacement therapy on spinal bone mineral density and T lymphocyte subsets in premature ovarian failure and Turner's syndrome.
    Kurabayashi T; Yasuda M; Fujimaki T; Yamamoto Y; Oda K; Tanaka K
    Int J Gynaecol Obstet; 1993 Jul; 42(1):25-31. PubMed ID: 8103471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome.
    Zeger MP; Shah K; Kowal K; Cutler GB; Kushner H; Ross JL
    Horm Res Paediatr; 2011; 75(1):38-46. PubMed ID: 20733274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Growth Hormone on Adult Bone Quality in Turner Syndrome: A HR-pQCT Study.
    Nour MA; Burt LA; Perry RJ; Stephure DK; Hanley DA; Boyd SK
    Calcif Tissue Int; 2016 Jan; 98(1):49-59. PubMed ID: 26439721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Turner syndrome adolescents receiving growth hormone are not osteopenic.
    Neely EK; Marcus R; Rosenfeld RG; Bachrach LK
    J Clin Endocrinol Metab; 1993 Apr; 76(4):861-6. PubMed ID: 8473397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen therapy initiated at an early age increases bone mineral density in Turner syndrome patients.
    Kodama M; Komura H; Kodama T; Nishio Y; Kimura T
    Endocr J; 2012; 59(2):153-9. PubMed ID: 22139404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
    Gravholt CH; Naeraa RW; Brixen K; Kastrup KW; Mosekilde L; Jørgensen JO; Christiansen JS
    Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or long-term GH replacement therapy.
    Rahim A; Holmes SJ; Adams JE; Shalet SM
    Clin Endocrinol (Oxf); 1998 Apr; 48(4):463-9. PubMed ID: 9640413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral density and fractures in Turner syndrome.
    Bakalov VK; Chen ML; Baron J; Hanton LB; Reynolds JC; Stratakis CA; Axelrod LE; Bondy CA
    Am J Med; 2003 Sep; 115(4):259-64. PubMed ID: 12967689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal changes of lumbar bone mineral density (BMD) in patients with GH deficiency after discontinuation of treatment at final height; timing and peak values for lumbar BMD.
    Baroncelli GI; Bertelloni S; Sodini F; Saggese G
    Clin Endocrinol (Oxf); 2004 Feb; 60(2):175-84. PubMed ID: 14725678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
    Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of estrogen replacement in young women with Turner syndrome.
    Hanton L; Axelrod L; Bakalov V; Bondy CA
    J Womens Health (Larchmt); 2003 Dec; 12(10):971-7. PubMed ID: 14709185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term hormone replacement therapy preserves bone mineral density in Turner syndrome.
    Cleemann L; Hjerrild BE; Lauridsen AL; Heickendorff L; Christiansen JS; Mosekilde L; Gravholt CH
    Eur J Endocrinol; 2009 Aug; 161(2):251-7. PubMed ID: 19447901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.